Cluster-randomized Study of 394 Patients Operated With Direct Anterolateral Approach.

March 9, 2018 updated by: Ammar Jobory, Lund University

Hip Precautions Not Meaningful After Hemiarthroplasty Due to Hip Fracture. Cluster-randomized Study of 394 Patients Operated With Direct Anterolateral Approach.

394 participants were cluster-randomized during 2010-2014. Depending on which ward the participants admitted to, they were allotted to free rehabilitation (non-precaution group, NPG, n=226) or our conventional regime with precautions and mandatory assistive equipment (precaution group, PG, n=168). The participants were followed during hospital stay, at 6 weeks (postal questionnaire), 3 month (visit) and 6 months (reading of medical records) by means of function tests, health-related quality of life (EQ-5D) and other patient-reported outcome measures (PROM).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

394 participants with Garden III-IV (20) femoral neck fractures treated with hemiarthroplasty participated in a cluster-randomised study during 2010-2014 at Skane University Hospital, Malmö. Inclusion criteria was an acute displaced femoral neck fracture treated with a bipolar hemiarthroplasty inserted via a direct lateral approach in supine position. All such participants were considered potential study participants and invited to the study by an occupational therapist (OT), within the first postoperative days. If the participants was not capable of making decisions, relatives were asked. The study was approved by The Regional Ethical Review Board in Lund on condition that all participants, regardless of group, or their next-in-kin gave written consent (Dnr 2009/754).

The four wards managing hip fracture patients were assigned either to provide the standard postoperative hip precaution regime or the non-precaution regime during the entire study period. In two of the wards, the precaution group (PG) had standard postoperative hip precautions included limited flexion of the hip to 90° (avoid reaching down to toes or bringing knee up beyond 90°) and limited adduction of the hip (avoid sleeping on side and avoid crossing legs at knees or ankles). The mandatory assistive equipment to use for at least 3 months were reacher and stocking application aid. The participants were instructed only to use elevated chair, bed and toilet in order not to flex more than 90° in the hip. For the same reason a brace over the knee was prescribed for 6 weeks, particularly in participants with cognitive limitations.

The non-precaution group (NPG) consisted of participants treated in the other two wards. Participants in the NPG had no restrictions on mobility, i.e. they were encouraged to move freely during the recovery phase and assistive equipment were prescribed only if needed.

Admittance of a participant to either ward was only decided by any available bed, i.e. the health status of the participants or any other factors did not influence placement of participants. The investigators recruited 168 participants to the PG and 226 participants to the NPG.

The initial power analysis was directed towards dislocation rate as primary outcome. When designing the trial, the investigators had a dislocation rate of 0.5% at the department. The investigators calculated that, in order to detect an increase of 3.5%, i.e. a clinical relevant effect, the investigators needed 340 participants in each group (p<0.05). The original plan was to additionally monitor PROM in the first 400 participants, and then dislocation rate only in the remaining 400. In order to monitor the safety of the study, the investigators also calculated a non-inferiority model, with warning levels at which the investigatorswould discontinue the study. This model was based on 200 participants in each group. Due to recruitment difficulties, the study was closed after inclusion of approximately 400 participants.

Both groups had functional assessment by an OT done as part of standard-of-care, usually within the three first postoperative days. The surgical procedure was a bipolar hemiarthroplasty inserted via a direct lateral approach (Hardinge). All implants were cemented, except 5 in the NPG and 2 in the PG (2.2 and 1.2 %).

During hospital stay the investigators registered time from admission to surgery, time of surgery, type of implant, adversities during surgery, the experience of the surgeon, radiological evaluation, length of stay, any deaths and dismissal address. The work burden of the rehabilitation personnel during hospital stay was estimated by themselves as "very short", "short", "normal", "long" or "very long" work effort. No one reported "very long". "Very short" and "short" was grouped together in the analyses. The participants were followed up with postal questionnaire at 6 weeks and 3 months including EQ-5D and a visual analogue scale on pain and satisfaction (0 to 100). A physiotherapist assessed participants with functional tests at 3 months. As only half of participants chose to participate in functional testing, the investigators do not report these data.

Medical records from all somatic departments of the hospital were reviewed and all adverse events (death, dislocation, surgical site infection (SSI), periprosthetic fracture, deep vein thrombosis, pulmonary embolism, pneumonia, falls and new fractures, stroke and ischemic heart attack) up to 6 months postoperatively were recorded. SSI was divided in to superficial incisional SSI and deep incisional SSI and were defined according to Horan et al.The follow-up cannot consider to be blinded, as some results were gathered during hospital stay were the group belonging of the participants were obvious.

Study Type

Interventional

Enrollment (Actual)

394

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with Garden III-IV (20) femoral neck fractures treated with hemiarthroplasty participated in a cluster-randomised study during 2010-2014.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: non-precaution group
Study Group: Patients in the NPG had no restrictions on mobility, i.e. they were encouraged to move freely during the recovery phase and assistive equipment were prescribed only if needed.
Patients in the NPG had no restrictions on mobility, i.e. they were encouraged to move freely during the recovery phase and assistive equipment were prescribed only if needed
No Intervention: precaution group
Control Group: the precaution group (PG) had standard postoperative hip precautions included limited flexion of the hip to 90° (avoid reaching down to toes or bringing knee up beyond 90°) and limited adduction of the hip (avoid sleeping on side and avoid crossing legs at knees or ankles). The mandatory assistive equipment to use for at least 3 months were reacher and stocking application aid. The patients were instructed only to use elevated chair, bed and toilet in order not to flex more than 90° in the hip. For the same reason a brace over the knee was prescribed for 6 weeks, particularly in patients with cognitive limitations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dislocation
Time Frame: 6 months
Dislocation of prosthesis identifed on x-ray
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROM
Time Frame: 3 months
EQ5D
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

December 31, 2014

Study Completion (Actual)

December 31, 2014

Study Registration Dates

First Submitted

February 12, 2018

First Submitted That Met QC Criteria

March 9, 2018

First Posted (Actual)

March 16, 2018

Study Record Updates

Last Update Posted (Actual)

March 16, 2018

Last Update Submitted That Met QC Criteria

March 9, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • AmmarJobory

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Non-precaution group

Search Similar Trials